Controversies in management of urinary tract infection.
D000667:Ampicillin / Q000627:therapeutic use; D001419:Bacteria / Q000254:growth & development; D002511:Cephalosporins / Q000378:metabolism / Q000627:therapeutic use; D004926:Escherichia coli / Q000472:pathogenicity; D005260:Female; D006090:Gram-Negative Bacteria / Q000472:pathogenicity; D006801:Humans; D007408:Intestinal Absorption; D007422:Intestines / Q000382:microbiology; D008297:Male; D009582:Nitrofurantoin / Q000378:metabolism / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000209:etiology / Q000382:microbiology / Q000628:therapy*
D002511:Cephalosporins; D000667:Ampicillin; D009582:Nitrofurantoin